BTIG and H.C. Wainwright & Co. are acting as co-lead managers with D. Boral Capital acting as co-manager for the offering.

D. Boral Capital keeps a Buy rating on Anavex Life Sciences (AVXL) with a $46 price target after Cassava Sciences’ (SAVA) Phase 3 trial for simufilam in mild-to-moderate Alzheimer’s disease ...

I think the rate of inflation will slow down in the coming year. We are continuing to progress our Good to Great strategy at Boral and with an improved performance we are in a position to continue ...

According to relationship and mental health experts, "bright siding" happens all the time, and it's something people often do with good intentions. Still, it can have disastrous consequences by ...

D. Boral Capital downgraded Citius Pharmaceuticals (CTXR) to Hold from Buy without a price target following the company’s announcement of a 1-for-25 reverse stock split. The reverse is partly a ...

Dave has had his head in PCs and gaming laptops for a couple of decades now, and knows what makes them tick, and what makes the best gaming laptop for every budget.Whether it's about looking for ...

‘It’s a term of endearment’: Why this restaurateur calls her customers sluts ...

An extra point is awarded to the driver and team who records the fastest lap (as long as they finished inside the top 10 points scoring positions). With the 2024 season comprising 24 races ...